About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, August 29th, 2016

The QualityStocks
Daily Stock List


Nutritional High International, Inc. (SPLIF)

SmallCapVoice and SECFilings.com News reported earlier on Nutritional High International, Inc. (SPLIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Nutritional High International, Inc. focuses on developing, manufacturing, and distributing products and nationally recognized brands in the hemp and marijuana-infused products industries. This includes edibles and oil extracts for nutritional, medical, and also adult recreational use. Nutritional High International is headquartered in Toronto, Ontario.

The Company works exclusively through licensed facilities in jurisdictions where such activity is permitted and regulated by state law. Nutritional High International says that it has a scalable, royalty-based business model with infrastructure and expertise to consistently ensure product quality.

Regarding its Hemp-Infused Products segment, it launched the first product in its Active Hemp category under the brand of “Nutritional Traditions”. Moreover, regarding its Hemp-Infused Products segment, first distribution will focus on California and Colorado by way of cannabis-related retail stores: medical marijuana dispensaries, vape lounges and headshops; and Food Supplement retail stores (including vitamin stores, supplement stores, and more).

Concerning its Marijuana-Infused Products segment, the Company centers on developing, acquiring, and designing Marijuana-Infused Products (MIPs) and Marijuana Concentrate products and brands. In this segment, it is establishing operations in Colorado and Illinois. Nutritional High International is working to expand into additional U.S. States in support of its business strategy to establish some of the first nationally-recognized brands for MIPs.

Last week, Nutritional High International reported that it received a license for its Illinois dispensary and held a successful open house at its dispensary in Effingham, Illinois. The Company was advised by the Illinois Department of Financial and Professional Regulation (IDFPR) that it has received all required registration information and that its subsidiary NH Medicinal Dispensaries, LLC (NHMD) is now licensed to operate the dispensary in Effingham, Illinois.

The Clinic Effingham will be working with eight different cultivators that grow the flowers and manufactures extracts. The cultivator centers also manufacture gummies, capsules, cookies, brownies, and other infused products.

Nutritional High International, Inc. (SPLIF), closed Monday's trading session at $0.0354, up 12.38%, on 178,255 volume with 14 trades. The average volume for the last 60 days is 75,194 and the stock's 52-week low/high is $0.017/$0.086.

TapImmune, Inc. (TPIV)

SeeThruEquityResearch, Stock Preacher, Beacon Equity Research, SuperStockTips, Penny Stock Craze, Penny Stocks Finder, InvestorSoup, Penny Pick Finders, Stock News Now, and Pennybuster reported on TapImmune, Inc. (TPIV), and today we report on the Company, here at the QualityStocks Daily Newsletter.

TapImmune, Inc. is a vaccine technologies company that specializes in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease. The Company is developing TAP-based (Transporters associated with Antigen Processing) prophylactic vaccines commercially suitable for the prevention of infectious diseases and as Biodefense agents. TapImmune is developing cancer vaccines that combine the use of novel antigens together with its TAP expression technology. Its technology has all-inclusive applications in developing therapeutic and preventative vaccines. TapImmune is headquartered in Jacksonville, Florida.

TapImmune’s peptide or nucleic acid-based immunotherapeutics, consist of one or multiple naturally processed epitopes (NPEs). The design of these is to comprehensively stimulate a patients' killer T-cells, helper T-cells, and to restore or further augment antigen presentation through utilizing proprietary nucleic acid-based expression systems.

TapImmune has developed a unique, cost effective, immunotherapeutic vaccine expression and delivery system. The novel platform is called TapImmune's PolyStart™ technology. The PolyStart and PAA (Peptide Antigen Array) technologies are straight forwardly and easily managed as a quick, adaptable, plugin-and-play system. This means they can be configured to produce peptides for any desired pathogen.

The Company’s PolyStart™ technology has been strategically designed to directly enhance the immune system's ability to stimulate either or both cytotoxic killer and helper T-cell reactive proprietary peptides, known and expected to be associated with one, or any cancer, infectious disease, or bio-threat. The present focus of its PolyStart technology is on its cancer program (e.g., Her2/neu and folate receptor alpha antigens).

TapImmune’s growth strategy is to conduct preclinical immunotherapeutic programs and move successes through to human trials; and develop a pipeline of Best in Class technology platforms that combine to make the most comprehensive T-Cell Immunotherapeutic vaccines in development. The Company’s growth strategy is also to discover, acquire, and develop technologies that modulate antigen presentation; commercialize proprietary products via corporate alliances; and develop business partnerships, which enhance the efficacy of other immunotherapeutic and vaccine products.

TapImmune signed an exclusive Licensing Option agreement with Mayo Clinic, of Rochester, Minnesota, for clinical development of a breast cancer vaccine technology. The Company has exercised its option agreement with Mayo Clinic and signed a worldwide license agreement to a proprietary HER2neu vaccine technology. The license gives TapImmune the right to develop and commercialize the technology in any cancer indication in which the Her2neu antigen is overexpressed.  This technology has completed Phase 1 clinical trials in HER2neu breast cancer patients.

Recently, TapImmune announced reaching a significant milestone of dosing its first patient in a Phase 2 trial for triple negative breast cancer with its cancer vaccine TPIV 200. The first patient enrolled is undergoing treatment at the University of Maryland. This is one of eight sites being used in the study, conducted and funded by TapImmune.

TapImmune, Inc. (TPIV), closed Monday's trading session at $0.471, down 0.32%, on 71,100 volume with 20 trades. The average volume for the last 60 days is 158,508 and the stock's 52-week low/high is $0.3077/$0.97.

RegeneRx Biopharmaceuticals, Inc. (RGRX)

PennyStockProphet, Penny Pick Finders, Planet Penny Stocks, Buzz Stocks, Stock Onion, Stock News Now, TopPennyStockMovers, and SmarTrend Newsletters reported earlier on RegeneRx Biopharmaceuticals, Inc. (RGRX), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.

RegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company listed on the OTCQB. It centers on tissue protection, repair and regeneration with a complete portfolio of product candidates for first-in-class therapeutic peptides. The Company’s mission is to research and develop novel pharmaceuticals that protect and repair tissue and organ damage caused by disease, trauma or other pathology. RegeneRx Biopharmaceuticals is headquartered in Rockville, Maryland.

RegeneRx holds multiple issued patents or filed patent applications globally to enable and protect multiple indications and applications for its product candidates. At present, the Company has three drug candidates in clinical development for ophthalmic, cardiac, and dermal indications. Furthermore, it has three active strategic licensing agreements in China, Pan Asia (Korea, Japan, and Australia, among others) and the United States and has a broad worldwide patent portfolio covering its products.

RegeneRx Biopharmaceuticals is centering on moving three distinct Tβ4-based drug candidates through the clinic. These are RGN-137, the aforementioned RGN-259, as well as RGN-352. RGN-137 is a topical gel formulation of the peptide Tβ4. RegeneRx is developing this as a novel treatment to hasten dermal healing. RegeneRx is also developing RGN-352. RGN-352 is its TB4-based injectable. This is a Phase 2-ready drug candidate designed to be administered systemically to prevent and restore tissue damage associated with acute events. This includes heart attacks, strokes, and other like traumatic injuries.  

RegeneRx Biopharmaceuticals is concentrating on the development of Thymosin beta 4 (a novel therapeutic peptide), for tissue and organ protection, repair and regeneration. RGN-259, its TB4-based ophthalmic drug candidate, has been designated an orphan drug for the treatment of neurotrophic keratopathy (NK), which is a primary focus of the Company's clinical development efforts in the U.S.

RegeneRx was earlier allowed by the Food and Drug Administration (FDA) to move into Phase III clinical trials with RGN-259 for the treatment of patients with neurotrophic keratopathy (NK). RGN-259 is a Tβ4-based sterile eye drop. RegeneRx is developing this as a novel treatment for corneal healing. In addition, the RGN-259 drug candidate is undergoing study in patients with dry eye syndrome in the U.S. and Asia.  RegeneRx, via its U.S. joint venture, ReGenTree LLC, is developing RGN-259 in the U.S.

Last week, RegeneRx Biopharmaceuticals announced that its U.S. joint venture, ReGenTree, LLC, received permission from the FDA to proceed with a second Phase 3 clinical trial using RGN-259 to treat patients with dry eye syndrome (DES). ReGenTree, LLC is a joint venture company between RegeneRx and GtreeBNT (a Korean Biopharmaceutical Company).

Today, RegeneRx Biopharmaceuticals announced that it received notice of Intent to Grant a patent from the European Patent Office for the treatment of patients with MS. The patent covers use of RegeneRx’s proprietary molecule Thymosin beta 4 (Tβ4) in a composition for treating or reducing deterioration of, injury or damage to tissue because of MS. The patent expiry is January 13, 2026.

RegeneRx Biopharmaceuticals, Inc. (RGRX), closed Monday's trading session at $0.3856, up 4.22%, on 83,400 volume with 17 trades. The average volume for the last 60 days is 32,868 and the stock's 52-week low/high is $0.28/$0.75.

BFC Financial Corp. (BFCF)

Marketbeat.com, Zacks, OTCPicks, SmallCap Fortunes, and Stock Traders Chat reported earlier on BFC Financial Corp. (BFCF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

BFC Financial Corp. is a diversified holding company headquartered in Fort Lauderdale, Florida. Its aim is to create long-term value for its shareholders through the profitable growth of its portfolio companies and appreciation in the value of its investments. BFC Financial lists on the OTCQB.

BFC Financial’s MAIN holdings include an 81 percent ownership interest in BBX Capital Corp. (BBX) and also its indirect ownership interest in Bluegreen Corp. Bluegreen is a wholly-owned subsidiary of Woodbridge Holdings, LLC. BFC Financial owns a 54 percent equity interest in Woodbridge Holdings. BBX Capital owns the remaining 46 percent equity interest in Woodbridge Holdings.

Additionally, BBX Capital Real Estate is a division of BBX Capital. BBX Capital Real Estate specializes in the development, operation, management, and investment in commercial and residential real estate and real estate lending. BBX Capital engages in the acquisition, ownership, and management of joint ventures (JV’s) and investments in real estate and real estate development projects. Also, it engages in acquisitions, investments, and management of middle market operating businesses.

BBX Capital Real Estate entered into a JV agreement this year with ContraVest to develop The Addison on Millenia. Case Pomeroy & CO is also an investor in the JV. The Addison on Millenia is within BBX Capital Real Estate's 47-acre mixed use development called Gardens on Millenia in Orlando, Florida.

At present, the expectation is that it will consist of ten, two, three and four story buildings with a total of 292 apartment homes. Located on an approximately 11.5-acre parcel, the expectation is that the community will feature a mix of one, two, and three-bedroom apartment homes ranging from 780 to 1,441 square feet.

Last month, BFC Financial and BBX Capital announced that they entered into a definitive merger agreement between the companies. With this merger agreement, BBX's shareholders other than BFC will be entitled to receive, at their election, 5.4 shares of BFC's Class A Common Stock or $20.00 in cash for each share of BBX's Class A Common Stock held by them.

This month, Bluegreen Corp.  announced the official opening of The Club Lodges at Trillium and welcomed its first guests. The Club Lodges at Trillium are in the heart of Cashiers, North Carolina. This mountain resort is in the heart of the Blue Ridge Mountains and on the shores of the 6-mile Lake Glenville. The Club Lodges at Trillium debuted twenty-six, 2 and 3-bedroom suites. Incorporated within Bluegreen Vacations' "fee-based services" business model, present plans for The Club Lodges at Trillium project upon completion are anticipated to total 78 units delivered in three phases.

BFC Financial Corp. (BFCF), closed Monday's trading session at $3.65, down 2.14%, on 64,831 volume with 55 trades. The average volume for the last 60 days is 70,798 and the stock's 52-week low/high is $2.50/$3.80.

Grow Solutions Holdings, Inc. (GRSO)

Profitable Trader Authority reported last week on Grow Solutions Holdings, Inc. (GRSO), Stockgoodies, PennyStockScholar, OTCtipReporter, StockRockandRoll, ResearchOTC, Journal Transcript, Elite Stock Alerts, and PennyStockLocks.com did earlier, and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Grow Solutions Holdings, Inc. provides complete support services in the broad area of high-yield indoor agriculture. The Company specializes in, but is not limited to the legal and regulated growing and processing of cannabis. Its mission is to be recognized as the world’s leading authority in the indoor high-yield agriculture industry. Grow Solutions’ shares trade on the OTC Markets Group’s OTCQB. The Company has its headquarters in New York, New York.

Grow Solutions’ diversified platform of operations and services for this industry consists of its Growth Technologies, Consumer Technologies, and Digital Properties divisions. In May of 2015, it acquired Boulder, Colorado-based One Love Garden Supply. One Love is a full service garden and grow store that Grow Solutions expanded to more than 7,000 square feet of space.

In addition, in September of 2015, Grow Solutions acquired HyGrow to expand its gardening supplies and agricultural products business. The acquisition enabled it to expand into Denver and Pueblo, Colorado.

This past March, Grow Solutions developed and launched FutureTech Products (Pompano, Florida-based). FutureTech develops products for the consumer market to sell in smoke shops, head shops, as well as dispensaries. Furthermore, this past April, Grow Solutions acquired Mile High Hydro. This is a full service online grow store. It offers a comprehensive line of gardening supply and agricultural products to growers across the nation.

Last week, Grow Solutions announced financial results for Q2 of 2016 ended June 30, 2016. For Q2 of 2016, net sales were $1,689,282. This represents an increase of 25 percent from sales of $1,353,624 for Q1 ending March 31, 2016, and an increase of 420 percent from sales of $325,051 for Q2 of 2015.

Gross profit was $352,094 for the three months ended June 30, 2016. This represents an increase of 484 percent versus gross profit of $60,140 for the three months ended June 30, 2015. Net loss for the three months ended June 30, 2016 was $601,778 versus $523,898 for the three months ended June 30, 2015.

Grow Solutions Holdings, Inc. (GRSO), closed Monday's trading session at $0.301, even for the day, on 16,000 volume with 2 trades. The average volume for the last 60 days is 4,628 and the stock's 52-week low/high is $0.255/$5.00.


The QualityStocks
Company Corner


OurPet's Company (OPCO)

The QualityStocks Daily Newsletter would like to spotlight OurPet's Company (OPCO). Today, OurPet's Company closed trading at $0.87, up 10.13%, on 1,512 volume with 2 trades. The stock’s average daily volume over the past 60 days is 4,315, and its 52-week low/high is $0.631/$1.06.

OurPet's Company (OPCO) develops, produces and markets various pet accessory and consumable products designed to awaken pets' natural instincts, be it in feeding, playing or waste management. Sold globally through pet specialty retailers, food, drug and mass chains, e-commerce and international channels, the company's products are marketed under a the OurPets®, Pet Zone® and PetTastic® brands with well-known sub-brands such as Play-N-Squeak™, Cosmic Catnip™, Durapet, SmartScoop and Flappy. In total, OurPet's has an intellectual property portfolio featuring more than 160 individual patents, giving the company sustainable access to the pet products industry for the foreseeable future.

In recent years, the U.S. pet products and services market has experienced strong growth, with total sales accounting for approximately $73 billion in 2014, according to a report by Packaged Facts. In 2015, this strong performance is expected to continue, building on the recent rise in related ecommerce purchases, as well as an uptick in dog and cat ownership throughout the country. In order to capitalize on this market performance, OurPet's maintains an ongoing new product development program to continually keep an evolutionary and revolutionary new product pipeline feeding its offerings. In July 2015, OurPet's introduced many new products at the national Super Zoo trade show in Las Vegas such as the Catty Whack®, Designer Diner™/Barking Bistro™ and the Zoom Plume™.

The company's capitalization strategy is guided by a management team of experienced industry professionals dedicated to further strengthening its product portfolio through aggressive development of innovative products. Management has a proven track-record of leveraging deep knowledge in the innovation, technology, distribution and pet markets to successfully push through adverse market conditions to achieve increases in revenue, margins and net income.

OurPet's, through its innovative and extensive line of popular pet products, is in a favorable strategic position to continue building upon its recent market growth. For prospective shareholders, this positioning makes the company an intriguing investment opportunity in the months to come. Look for OurPet's to capitalize on steady market performance moving forward, providing an opportunity for the company to realize strong investor returns in the future. Disclaimer

OurPet's Company Company Blog

OurPet's Company News:

OurPet’s Company Reports Results for 2016 Second Quarter

OurPet's Company (OPCO) Has a New Natural Solution to Your Cat Litter Woes

OurPet's Company Now Licensing Polymer Bonded Pet Bowl Patent

Alternet Systems, Inc. (ALYI)

The QualityStocks Daily Newsletter would like to spotlight Alternet Systems, Inc. (ALYI). Today, Alternet Systems, Inc. closed trading at $0.0048, up 5.73%, on 15,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 66,637, and its 52-week low/high is $0.0021/$0.029.

Alternet Systems, Inc. (ALYI) invests in and partners with companies that are creating the future of money in the high growth, emerging technology fields of digital commerce, multichannel payments, and predictive analytics.

Vision: Be the leading digital commerce, multichannel payments, predictive analytics solutions provider into global markets

Mission: To provide innovative solutions that facilitates and expedites commerce, enriching our partners and their customers' experience, and improving efficiency. Recognizing that the world is becoming increasingly dependent on technological conveniences, Alternet Systems aims to provide its customers with the tools to prepare themselves for a new era of digital commerce and payments, financial services and consumer information, and, most importantly, a new era of how to live.

Since 2010, Alternet has maintained a progressive focus on the high-growth, mobile value-added service industries of mobile financial services and mobile security. In 2014, the company expanded its scope of expertise to include in its investment verticals the exciting digital commerce space, transforming the legacy electronic payments infrastructure and developing advanced predictive data analytics applications for the mass consumer, telecommunications and financial industry.

With strategic investments in these three key, high-growth markets, Alternet is accelerating the future of money and its role in the global demand for these services. The company is guided by a team of executives specializing in entrepreneurial endeavors, innovation, corporate strategy, financial and executive management of multi-national organizations, and a vast network of industry resources.

As Alternet embarks on this new path, the company will be led by a management team and board of directors with over a century's worth of combined experience in the fields of investing, technology, and financing, and the consensus knowledge of where to invest and when in start-up and early-stage companies. Disclaimer

Alternet Systems, Inc. Company Blog

Alternet Systems, Inc. News:

Alternet Systems Data Analytics Solution Gains Momentum with New Clients and Partners

Alternet Systems Announces Caprock Research Report with Near Term Price Target of $0.05 and 'Accumulate' Recommendation

Alternet Systems Launches Data Analytics Division To Build On Existing Revenue Base

Dominovas Energy Corp. (DNRG)

The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.0021, up 5.00%, on 27,752,233 volume with 137 trades. The stock’s average daily volume over the past 60 days is 12,563,294 and its 52-week low/high is $0.0015/$0.143.

Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.

At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.

In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.

Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer

Dominovas Energy Corp. Blog

Dominovas Energy Corp. News:

Dominovas Energy Set to Deliver Its Rubicon Showcase

Dominovas Energy Issues Open Letter to Shareholders

Dominovas Energy Announces Plan to Restructure and Consolidate Outstanding Debt

eXp World Holdings, Inc. (EXPI)

The QualityStocks Daily Newsletter would like to spotlight eXp World Holdings, Inc. (EXPI). Today, eXp World Holdings, Inc. closed trading at $3.00, up 2.39%, on 10,793 volume with 25 trades. The stock’s average daily volume over the past 60 days is 9,903, and its 52-week low/high is $0.51/$3.15.

eXp World Holdings, Inc. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.

Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.

Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.

Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer

eXp World Holdings, Inc. Company Blog

eXp World Holdings, Inc. News:

Fundamental Research Corp. Updates Its Coverage of eXp World Holdings, Inc.

eXp Realty Launches in Alaska

Russ Cofano Joins eXp World Holdings and eXp Realty

Moxian, Inc. (MOXC)

The QualityStocks Daily Newsletter would like to spotlight Moxian, Inc. (MOXC). Today, Moxian, Inc. closed trading at $6.20, up 1.64%, on 265 volume with 3 trades. The stock’s average daily volume over the past 60 days is 57, and its 52-week low/high is $5.80/$11.70.

Moxian, Inc. (MOXC) engages in the business of providing social marketing and promotion platforms designed to help merchants accelerate and advertise their business growth through social media. These products and services enable merchants to run targeted advertising campaigns and promotions, and aim to enhance the interaction between users and merchant clients by using consumer behavior data compiled from the Moxian database of user activities. The company has two primary core products: Moxian+ User App and Moxian+ Business App.

Developed in Shenzhen, China, Moxian integrates social media, entertainment and business intelligence. The Multi-Channel Social Commerce Platform, which includes a variety of tools such as Moxian's proprietary Social Customer Relationship Management (SCRM) system, generates knowledgeable data for merchants. This way, consumers and businesses are able to connect and interact with one another to achieve the concept of "online lifestyle, offline fun."

Moxian+ User App serves as an App driven for consumer users to use the platform, consisting of our proprietary virtual currency (MO-Coin and MO-Points), social networking, redemption centre and game centre. Users can earn MO-Coins by playing games, and then use those coins to redeem prizes sponsored by Moxian and client merchants. This model not only drives registered consumers to Moxian and merchant, but also provides merchants the opportunity to advertise, run marketing campaigns, and learn about their customers through the Platform.

Moxian+ Business App is an independent App with built in Social Customer Relationship Management tool built for merchants. Merchants are able to set up a store on the Moxian platform through this business App, push promotions via a variety of methods offered on the platform and look at generated report customized to their own shop.

Moxian's management team has more than 100 years of combined experience in a variety of pertinent endeavors, including management of private and public enterprise, multi-national organizations, quality, engineering and procurement, finance, marketing, communication and more. Together, Moxian's management team is effecting the company's aim to create and lead a personalized social network platform that best fits users and businesses. Disclaimer

Moxian, Inc. Company Blog

Moxian, Inc. News:

Moxian Adopts Oracle Database Solutions to Support the Latest Payment and Transaction Platform, Enabling Intelligent Big Data

Moxian Enters Into Exclusive Agreement and Development Partnership With Xinhua Media Affiliate

Moxian, Inc. Covered by Crystal Equity Research


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



Stock Beast


Profitable Trader Authority



By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251